EUVIMEDEUVIMED entdecken
Crossref

Developments on mammalian oocyte maturation using ZHB112–113, a novel long-acting human FSH and LH recombinant fusion protein

Puyao Zhang, Chennan Ge, Chenyang Jiang, Yu Zhuang, Mengqian Zhu, Min Chen, Xuning Ding, Bruce Yong Ma iD

Biology of Reproduction · 2026

DOI: 10.1093/biolre/ioag004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biology of Reproduction, 2026. Verfasst von Puyao Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Med-Z Institute, ZonHon Biopharma Institute, Inc., Changzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Luteinizing Hormone, Oocytes, Follicle Stimulating Hormone, Recombinant Fusion Proteins. Die Arbeit nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian stimulation medications are critical in assisted reproductive technology (ART), with growing demand for long-acting follicle-stimulating hormone (FSH). Although luteinizing hormone (LH) plays a pivotal role in oocyte maturation, recombinant long-acting LH remains underexplored. Here we develop a novel recombinant protein with an extended in vivo half-life and dual FSH and LH bioactivity to improve ovarian stimulation efficacy. This protein successfully induced ovarian stimulation in both mice and cynomolgus monkeys, confirming robust reproductive hormonal activity. The findings indicate its potential as an ovarian stimulation agent in ART, although further optimization of stimulation protocols is required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Luteinizing HormoneOocytesFollicle Stimulating HormoneRecombinant Fusion ProteinsOogenesisFollicle Stimulating Hormone, HumanAnimalsFemaleMiceHumansOvulation InductionMacaca fascicularis

Stichwörter der Autor:innen

assisted reproductive technology (ART)oocyte maturationrecombinant long-acting FSH/LH

Substanzen

Luteinizing HormoneFollicle Stimulating HormoneRecombinant Fusion ProteinsFollicle Stimulating Hormone, Human

Autor:innen und Institutionen

  • Med-Z Institute, ZonHon Biopharma Institute, Inc., Changzhou, Jiangsu, China.
  • Jiangsu Engineering Research Center for Precision Biomedicines, ZonHon Biopharma Institute, Inc., Changzhou, Jiangsu, China.
  • Bio-Z Institute, ZonHon Biopharma Institute, Inc., Changzhou, Jiangsu, China.
  • Pharma-Z Institute, ZonHon Biopharma Institute, Inc., Changzhou, Jiangsu, China.
  • ZonHon Biopharma Institute, Inc., Changzhou, Jiangsu, China.

ORCID-Profile: Bruce Yong Ma

Zitieren

APA

Zhang, P., Ge, C., Jiang, C., Zhuang, Y., Zhu, M., Chen, M., Ding, X., & Ma, B. Y. (2026). Developments on mammalian oocyte maturation using ZHB112–113, a novel long-acting human FSH and LH recombinant fusion protein. Biology of Reproduction. https://doi.org/10.1093/biolre/ioag004

Vancouver

Zhang P, Ge C, Jiang C, Zhuang Y, Zhu M, Chen M, et al. Developments on mammalian oocyte maturation using ZHB112–113, a novel long-acting human FSH and LH recombinant fusion protein. Biology of Reproduction. 2026. doi:10.1093/biolre/ioag004

BibTeX
@article{Zhang2026,
  author = {Zhang, Puyao and Ge, Chennan and Jiang, Chenyang and Zhuang, Yu and Zhu, Mengqian and Chen, Min and Ding, Xuning and Ma, Bruce Yong},
  title = {Developments on mammalian oocyte maturation using ZHB112–113, a novel long-acting human FSH and LH recombinant fusion protein},
  journal = {Biology of Reproduction},
  year = {2026},
  doi = {10.1093/biolre/ioag004}
}
Kostenlos starten →